- Published on
Ophthalmology – Chronic Progressive External Ophthalmoplegia (CPEO)
Chronic Progressive External Ophthalmoplegia (CPEO) is a clinical manifestation of mitochondrial cytopathies, a group of disorders caused by dysfunction of mitochondria due to mutations in either mitochondrial DNA or nuclear genes encoding mitochondrial components. It is not a single disease entity but rather a phenotype that can occur within a spectrum of systemic mitochondrial disorders affecting high-energy tissues such as muscle, brain, and heart. A notable associated condition is Kearns–Sayre syndrome (KSS), which includes CPEO, pigmentary retinopathy, and systemic features such as cardiac conduction defects and endocrine abnormalities.
Epidemiologically, CPEO most commonly presents in childhood or early adolescence, although onset can occur at any age. Most cases are sporadic due to single large-scale mitochondrial DNA deletions arising during oocyte development. Less commonly, inherited forms follow autosomal dominant or recessive patterns involving nuclear genes such as POLG or Twinkle. A key concept in mitochondrial disease is heteroplasmy, where varying proportions of normal and mutated mitochondrial DNA determine disease expression once a threshold is exceeded in energy-dependent tissues.
The pathophysiology centers on impaired mitochondrial oxidative phosphorylation, leading to decreased ATP production and dysfunction of cellular processes such as apoptosis regulation, reactive oxygen species detoxification, and metabolic pathways. Extraocular muscles are particularly vulnerable due to their high metabolic demand, explaining the prominent ophthalmic manifestations.
Clinically, patients present with slowly progressive bilateral ptosis and symmetric limitation of eye movements (ophthalmoplegia), typically sparing the pupils. Other systemic features may include limb weakness, hearing loss, ataxia, short stature, seizures, and endocrine abnormalities. In Kearns–Sayre syndrome, a characteristic “salt-and-pepper” pigmentary retinopathy may be observed. Importantly, cardiac conduction abnormalities can occur and may be life-threatening.
Diagnosis involves a combination of clinical findings, laboratory testing, imaging, and confirmatory biopsy. Blood tests may show elevated lactate or creatine kinase, while electrocardiography is essential to detect cardiac involvement. Neuroimaging may reveal thin extraocular muscles or brain abnormalities. The gold standard for diagnosis is skeletal muscle biopsy demonstrating ragged-red fibers, representing accumulation of abnormal mitochondria. Genetic testing is increasingly used to confirm mutations.
Differential diagnosis includes other causes of ptosis and ophthalmoplegia such as Myasthenia gravis, congenital myopathies, and muscular dystrophies. Careful clinical evaluation and testing help distinguish these conditions.
There is no definitive cure for CPEO, and management is largely supportive. Surgical correction of ptosis may improve vision but must be approached cautiously due to poor eyelid closure and risk of exposure keratopathy. Strabismus surgery can help alleviate diplopia in selected patients. Systemic complications require targeted management, including pacemaker placement for cardiac conduction defects, endocrine therapy for metabolic disturbances, and antiepileptic treatment for seizures.
Adjunctive therapies such as vitamin supplementation (e.g., coenzyme Q10, vitamin B complex) are sometimes used, although evidence for their effectiveness is limited. Patients are advised to avoid mitochondrial stressors such as smoking and excessive alcohol consumption. Genetic counseling is important, particularly for families with inherited forms.
The prognosis is characterized by a slow, progressive course. While ocular motility continues to decline over time, life expectancy depends largely on the severity of systemic involvement, particularly cardiac complications.
Complications include cardiac conduction defects, endocrine dysfunction, progressive muscle weakness, and visual disability related to ptosis and ophthalmoplegia. Early recognition and multidisciplinary care are essential to reduce morbidity and prevent life-threatening complications.
- Published on
Ophthalmology – Canaliculitis
Canaliculitis is an acute or chronic inflammation of the lacrimal canalicular system, most often affecting the lower canaliculus. It is a relatively rare condition but occurs more frequently in adults and shows a strong female predominance (approximately 6:1). The condition is often underdiagnosed because it can mimic other causes of chronic red eye or discharge.
The underlying pathophysiology involves obstruction of the canaliculus, which leads to stagnation of tears and subsequent infection. Over time, this results in inflammation and the formation of concretions (dacryoliths) within the canaliculus. These concretions can harbor bacteria and make the infection persistent or recurrent.
The most common causative organisms include Streptococcus and Staphylococcus species, as well as Actinomyces and Propionibacterium. In many cases, infections are polymicrobial. Risk factors include prior placement of intracanalicular plugs, recurrent conjunctivitis, dacryocystitis, and chronic dry eye conditions.
Patients typically present with epiphora (excessive tearing), localized pain, and swelling near the punctum. A key feature is mucopurulent discharge, often expressed when pressure is applied over the canaliculus. On examination, the punctum may appear dilated and edematous, and the canaliculus is usually tender and erythematous. Slit-lamp examination often reveals discharge from the punctum and localized inflammation.
Diagnosis is largely clinical but can be supported by additional findings. Expression or probing of the canaliculus may yield concretions, which is highly diagnostic. Cultures and sensitivity testing can help guide antibiotic therapy, and fungal cultures may be considered in atypical cases. If the condition appears to extend beyond the canaliculus, imaging such as dacryocystography may be used to evaluate for deeper involvement or foreign bodies.
The differential diagnosis includes conditions such as dacryocystitis, chalazion, and mucopurulent conjunctivitis. Differentiation is important because treatment strategies differ significantly.
Initial treatment includes topical antibiotics, such as penicillin eye drops (100,000 units/mL) four times daily for two weeks, or sodium sulfacetamide if penicillin is unavailable. Warm compresses are also recommended to help reduce inflammation and promote drainage. However, medical therapy alone is often insufficient.
Definitive treatment typically requires a minor surgical procedure. Canaliculotomy, which involves making an incision into the canaliculus, allows for removal of all concretions. Complete removal is essential for cure, as retained material can lead to recurrence. Postoperatively, patients are usually treated with broad-spectrum antibiotic drops.
Prognosis is excellent, with nearly 100% cure rates when all concretions are removed. Complications are uncommon but may include recurrence if debris is not completely cleared, or, rarely, canalicular scarring leading to persistent tearing. Early recognition and appropriate management are key to preventing chronic symptoms and recurrence.
- Published on
Ophthalmology – Bullous Keratopathy
Bullous keratopathy is a corneal condition caused by endothelial failure, leading to chronic corneal edema and the formation of epithelial bullae (fluid-filled blisters). These bullae may rupture, resulting in episodes of significant ocular pain. The condition is most commonly seen after intraocular surgery, particularly cataract surgery, although its incidence has decreased with advances in surgical techniques and intraocular lens design. The risk is higher in complicated surgeries involving vitreous loss, anterior chamber lenses, or in patients with preexisting endothelial dysfunction such as Fuchs endothelial dystrophy.
The underlying pathophysiology involves progressive loss or dysfunction of corneal endothelial cells, which are responsible for maintaining corneal dehydration and clarity. As endothelial cells are lost, the remaining cells enlarge and become irregular in shape (polymegathism and pleomorphism). Eventually, the endothelial pump fails, leading to stromal swelling and fluid accumulation. This fluid extends into the epithelium, forming vesicles that may coalesce into bullae. When these bullae rupture, they expose corneal nerve endings, causing severe pain. Vision impairment is primarily due to epithelial edema, although stromal changes also contribute.
Patients typically present with gradually worsening blurred or “misty” vision, especially in the morning. This occurs because corneal edema worsens overnight due to reduced evaporation and decreased endothelial activity. Vision may improve as the day progresses, although this becomes less noticeable as the disease advances. Other symptoms include foreign body sensation, irritation, photophobia, tearing, and recurrent episodes of severe pain when bullae rupture.
On examination, the cornea appears dull and edematous. Slit-lamp findings include epithelial irregularities, superficial punctate keratitis, and bullae that may be intact (appearing as dark spots with fluorescein) or ruptured (staining brightly). Stromal edema presents as increased corneal thickness with fluid clefts, and folds in Descemet’s membrane may be visible. In advanced cases, corneal vascularization may develop. Associated findings may point to underlying causes, such as guttata in Fuchs dystrophy or signs of chronic uveitis or glaucoma.
Diagnostic evaluation may include specular microscopy, which demonstrates decreased endothelial cell density and abnormal cell morphology. Confocal microscopy can reveal epithelial bullae, stromal edema, and loss of corneal nerves. Pachymetry is useful in measuring corneal thickness; values greater than 590 μm in pseudophakic eyes suggest irreversible edema. These tools help assess severity and guide management.
Treatment focuses on symptom relief and, when possible, restoration of vision. Initial management includes hypertonic saline (5%) drops or ointment to reduce corneal edema, often used multiple times daily. Blowing warm air (such as from a hair dryer) across the eye can promote evaporation and reduce edema. Intraocular pressure should be controlled if elevated. For persistent symptoms, extended-wear soft contact lenses may be used to protect the corneal surface and reduce pain, although they carry risks such as infection and hypoxia.
Definitive treatment is corneal transplantation, either endothelial keratoplasty or penetrating keratoplasty, particularly in patients with visual potential. In patients who are not candidates for transplantation or lack visual potential, several palliative procedures may be considered. These include anterior stromal puncture to promote epithelial adherence, phototherapeutic keratectomy, and amniotic membrane transplantation to facilitate healing and reduce pain. In severe, painful cases without visual potential, more aggressive measures such as retrobulbar alcohol injection or even eye removal procedures may be required.
Complications of bullous keratopathy include corneal ulceration, secondary infection, scarring, vascularization, and reduced corneal sensitivity. The diseased epithelium is particularly vulnerable to infection, especially when protective measures like bandage contact lenses are used. Early recognition and appropriate management are essential to relieve symptoms and preserve vision where possible.
Bullous keratopathy is a corneal condition caused by endothelial failure, leading to chronic corneal edema and the formation of epithelial bullae (fluid-filled blisters). These bullae may rupture, resulting in episodes of significant ocular pain. The condition is most commonly seen after intraocular surgery, particularly cataract surgery, although its incidence has decreased with advances in surgical techniques and intraocular lens design. The risk is higher in complicated surgeries involving vitreous loss, anterior chamber lenses, or in patients with preexisting endothelial dysfunction such as Fuchs endothelial dystrophy.
The underlying pathophysiology involves progressive loss or dysfunction of corneal endothelial cells, which are responsible for maintaining corneal dehydration and clarity. As endothelial cells are lost, the remaining cells enlarge and become irregular in shape (polymegathism and pleomorphism). Eventually, the endothelial pump fails, leading to stromal swelling and fluid accumulation. This fluid extends into the epithelium, forming vesicles that may coalesce into bullae. When these bullae rupture, they expose corneal nerve endings, causing severe pain. Vision impairment is primarily due to epithelial edema, although stromal changes also contribute.
Patients typically present with gradually worsening blurred or “misty” vision, especially in the morning. This occurs because corneal edema worsens overnight due to reduced evaporation and decreased endothelial activity. Vision may improve as the day progresses, although this becomes less noticeable as the disease advances. Other symptoms include foreign body sensation, irritation, photophobia, tearing, and recurrent episodes of severe pain when bullae rupture.
On examination, the cornea appears dull and edematous. Slit-lamp findings include epithelial irregularities, superficial punctate keratitis, and bullae that may be intact (appearing as dark spots with fluorescein) or ruptured (staining brightly). Stromal edema presents as increased corneal thickness with fluid clefts, and folds in Descemet’s membrane may be visible. In advanced cases, corneal vascularization may develop. Associated findings may point to underlying causes, such as guttata in Fuchs dystrophy or signs of chronic uveitis or glaucoma.
Diagnostic evaluation may include specular microscopy, which demonstrates decreased endothelial cell density and abnormal cell morphology. Confocal microscopy can reveal epithelial bullae, stromal edema, and loss of corneal nerves. Pachymetry is useful in measuring corneal thickness; values greater than 590 μm in pseudophakic eyes suggest irreversible edema. These tools help assess severity and guide management.
Treatment focuses on symptom relief and, when possible, restoration of vision. Initial management includes hypertonic saline (5%) drops or ointment to reduce corneal edema, often used multiple times daily. Blowing warm air (such as from a hair dryer) across the eye can promote evaporation and reduce edema. Intraocular pressure should be controlled if elevated. For persistent symptoms, extended-wear soft contact lenses may be used to protect the corneal surface and reduce pain, although they carry risks such as infection and hypoxia.
Definitive treatment is corneal transplantation, either endothelial keratoplasty or penetrating keratoplasty, particularly in patients with visual potential. In patients who are not candidates for transplantation or lack visual potential, several palliative procedures may be considered. These include anterior stromal puncture to promote epithelial adherence, phototherapeutic keratectomy, and amniotic membrane transplantation to facilitate healing and reduce pain. In severe, painful cases without visual potential, more aggressive measures such as retrobulbar alcohol injection or even eye removal procedures may be required.
Complications of bullous keratopathy include corneal ulceration, secondary infection, scarring, vascularization, and reduced corneal sensitivity. The diseased epithelium is particularly vulnerable to infection, especially when protective measures like bandage contact lenses are used. Early recognition and appropriate management are essential to relieve symptoms and preserve vision where possible.
- Published on
Infectious Disease and Microbiology - Lymphangitis
Lymphangitis is an inflammatory condition of the lymphatic channels that typically occurs as a result of infection at a distal site. The condition arises when pathogens enter the lymphatic vessels through a break in the skin, such as a cut, abrasion, insect bite, or underlying skin infection, and spread proximally toward regional lymph nodes. It is commonly associated with visible red streaks extending from the site of infection.
Although specific epidemiologic data are limited, several risk factors predispose individuals to lymphangitis. These include lymphedema, trauma, insect bites or stings, and preexisting skin conditions such as fungal infections like tinea pedis. Children with underlying conditions such as diabetes, immunodeficiency, or those receiving chronic steroid therapy are at increased risk of developing more severe or rapidly progressive disease.
The pathophysiology involves direct invasion of lymphatic vessels by microorganisms. Once pathogens enter, they trigger local inflammation, leading to characteristic erythematous streaking along lymphatic channels. The infection may then spread toward regional lymph nodes, causing lymphadenopathy and systemic symptoms if dissemination occurs.
The most common causative organisms in immunocompetent individuals are group A beta-hemolytic streptococci. Staphylococcus aureus is another frequent pathogen, while other organisms such as Pseudomonas species, Pasteurella multocida (associated with animal bites), and Aeromonas hydrophila (associated with freshwater exposure) may also be involved. In immunocompromised hosts, gram-negative bacteria and fungi may play a role. Nodular lymphangitis, characterized by a sporotrichoid pattern, is often associated with organisms such as Sporothrix schenckii, Mycobacterium marinum, and Nocardia brasiliensis.
Patients typically present with a history of recent skin trauma or infection. Symptoms often include fever, chills, malaise, and localized pain. On physical examination, erythematous, warm, and tender linear streaks are seen extending from the primary infection site toward regional lymph nodes. The primary lesion may be an abscess, cellulitis, or infected wound. Regional lymph nodes are often enlarged and tender, and systemic signs such as tachycardia may be present in more severe cases.
Diagnosis is primarily clinical but may be supported by laboratory findings. A complete blood count often reveals leukocytosis, and blood cultures may be obtained, although they are frequently negative. Culture and Gram staining of material from the primary infection site can help identify the causative organism and guide antimicrobial therapy. In cases of nodular lymphangitis, cultures for fungi and mycobacteria or histopathological examination may be necessary. Imaging is generally not required in routine cases.
Management involves prompt initiation of appropriate antimicrobial therapy targeting the most likely pathogens, particularly streptococci and Staphylococcus aureus. Outpatient treatment may include penicillinase-resistant penicillins or first-generation cephalosporins, while more severe cases require intravenous antibiotics such as second- or third-generation cephalosporins. In regions with high prevalence of methicillin-resistant Staphylococcus aureus, agents such as clindamycin or trimethoprim-sulfamethoxazole may be considered. Supportive measures, including analgesics, anti-inflammatory medications, and warm compresses, can help alleviate symptoms. Abscesses, if present, may require incision and drainage.
Close monitoring is essential, especially in children and patients with systemic symptoms. Those who do not respond to oral therapy within 48 hours or who exhibit signs of systemic illness should receive intravenous treatment. Preventive measures include proper wound care, management of underlying skin conditions, and protection against skin trauma.
The prognosis for uncomplicated lymphangitis is generally excellent, with most patients responding well to antimicrobial therapy. However, if left untreated, the infection can progress rapidly, leading to complications such as cellulitis, bacteremia, sepsis, and, in severe cases, tissue necrosis or death. Prompt recognition and treatment are therefore critical.
Lymphangitis is an inflammatory condition of the lymphatic channels that typically occurs as a result of infection at a distal site. The condition arises when pathogens enter the lymphatic vessels through a break in the skin, such as a cut, abrasion, insect bite, or underlying skin infection, and spread proximally toward regional lymph nodes. It is commonly associated with visible red streaks extending from the site of infection.
Although specific epidemiologic data are limited, several risk factors predispose individuals to lymphangitis. These include lymphedema, trauma, insect bites or stings, and preexisting skin conditions such as fungal infections like tinea pedis. Children with underlying conditions such as diabetes, immunodeficiency, or those receiving chronic steroid therapy are at increased risk of developing more severe or rapidly progressive disease.
The pathophysiology involves direct invasion of lymphatic vessels by microorganisms. Once pathogens enter, they trigger local inflammation, leading to characteristic erythematous streaking along lymphatic channels. The infection may then spread toward regional lymph nodes, causing lymphadenopathy and systemic symptoms if dissemination occurs.
The most common causative organisms in immunocompetent individuals are group A beta-hemolytic streptococci. Staphylococcus aureus is another frequent pathogen, while other organisms such as Pseudomonas species, Pasteurella multocida (associated with animal bites), and Aeromonas hydrophila (associated with freshwater exposure) may also be involved. In immunocompromised hosts, gram-negative bacteria and fungi may play a role. Nodular lymphangitis, characterized by a sporotrichoid pattern, is often associated with organisms such as Sporothrix schenckii, Mycobacterium marinum, and Nocardia brasiliensis.
Patients typically present with a history of recent skin trauma or infection. Symptoms often include fever, chills, malaise, and localized pain. On physical examination, erythematous, warm, and tender linear streaks are seen extending from the primary infection site toward regional lymph nodes. The primary lesion may be an abscess, cellulitis, or infected wound. Regional lymph nodes are often enlarged and tender, and systemic signs such as tachycardia may be present in more severe cases.
Diagnosis is primarily clinical but may be supported by laboratory findings. A complete blood count often reveals leukocytosis, and blood cultures may be obtained, although they are frequently negative. Culture and Gram staining of material from the primary infection site can help identify the causative organism and guide antimicrobial therapy. In cases of nodular lymphangitis, cultures for fungi and mycobacteria or histopathological examination may be necessary. Imaging is generally not required in routine cases.
Management involves prompt initiation of appropriate antimicrobial therapy targeting the most likely pathogens, particularly streptococci and Staphylococcus aureus. Outpatient treatment may include penicillinase-resistant penicillins or first-generation cephalosporins, while more severe cases require intravenous antibiotics such as second- or third-generation cephalosporins. In regions with high prevalence of methicillin-resistant Staphylococcus aureus, agents such as clindamycin or trimethoprim-sulfamethoxazole may be considered. Supportive measures, including analgesics, anti-inflammatory medications, and warm compresses, can help alleviate symptoms. Abscesses, if present, may require incision and drainage.
Close monitoring is essential, especially in children and patients with systemic symptoms. Those who do not respond to oral therapy within 48 hours or who exhibit signs of systemic illness should receive intravenous treatment. Preventive measures include proper wound care, management of underlying skin conditions, and protection against skin trauma.
The prognosis for uncomplicated lymphangitis is generally excellent, with most patients responding well to antimicrobial therapy. However, if left untreated, the infection can progress rapidly, leading to complications such as cellulitis, bacteremia, sepsis, and, in severe cases, tissue necrosis or death. Prompt recognition and treatment are therefore critical.
- Published on
Infectious Disease and Microbiology - Lyme disease
Lyme disease is a multisystem, tick-borne infection caused by spirochetes of the genus Borrelia. It typically begins at the site of a bite from an infected Ixodes tick, followed by local spread in the skin and eventual dissemination through the bloodstream or lymphatic system to multiple organs, including joints, the nervous system, heart, and skin. The disease progresses through three stages: early localized, early disseminated, and late disease. It was first recognized in 1977 after a cluster of arthritis cases in children near Lyme, Connecticut.
Epidemiologically, Lyme disease is the most common tick-borne infection in North America and Europe. The highest incidence occurs in specific endemic regions, particularly along the northeastern United States and parts of the Midwest. Risk is strongly associated with outdoor activities such as hiking, camping, or occupational exposure in wooded or grassy areas where ticks are prevalent. Transmission usually requires the tick to remain attached for more than 36 hours, although many patients do not recall a tick bite. Preventive strategies include wearing protective clothing, using insect repellents such as DEET, and prompt tick removal. In certain high-risk exposures, a single prophylactic dose of doxycycline may be considered.
The causative organism in the United States is Borrelia burgdorferi, while Borrelia afzelii and Borrelia garinii are more common in Europe and Asia. After entering the skin, the organism spreads locally and may later disseminate systemically. The clinical manifestations depend on the stage of the disease and the host immune response.
In early localized disease, the hallmark finding is erythema migrans, an expanding skin lesion that appears days to weeks after the tick bite. It often presents as a red macule or papule that enlarges into a characteristic annular rash with central clearing. This stage may also be accompanied by mild systemic symptoms such as fever, fatigue, and headache.
Early disseminated disease occurs weeks to months later and involves multiple organ systems. Patients may develop multiple secondary skin lesions, migratory musculoskeletal pain, and neurologic manifestations such as meningitis or facial nerve palsy. Cardiac involvement may occur, most commonly presenting as atrioventricular conduction abnormalities. Ocular symptoms and mild hepatitis may also be seen.
Late disease develops months to years after untreated infection and is characterized primarily by chronic arthritis, especially affecting large joints such as the knee. Neurologic complications may include encephalopathy or polyneuropathy. Certain dermatologic manifestations, such as acrodermatitis chronica atrophicans, are more commonly observed in Europe. Some patients may experience persistent symptoms such as fatigue or cognitive difficulties after treatment, a condition referred to as post–Lyme disease syndrome.
Diagnosis is based on clinical findings, history of exposure, and laboratory testing. A two-step serologic approach is recommended, beginning with an enzyme immunoassay or immunofluorescence assay, followed by confirmatory Western blot testing if positive or equivocal. Laboratory testing has limitations, particularly in early disease when antibodies may not yet be detectable. PCR testing may be useful in certain cases, such as analysis of synovial or cerebrospinal fluid.
Treatment depends on the stage and manifestations of the disease. Early disease is typically treated with oral antibiotics such as doxycycline, amoxicillin, or cefuroxime. More severe or disseminated disease, particularly with neurologic or cardiac involvement, may require intravenous therapy with ceftriaxone. The duration of therapy varies from 2 to 4 weeks depending on the clinical scenario. In cases of persistent arthritis or complications, additional supportive or symptomatic treatments may be required.
The prognosis is generally excellent when Lyme disease is recognized and treated early. However, delayed diagnosis may result in chronic complications such as persistent arthritis or neurologic impairment. Careful monitoring and appropriate management of complications are essential to ensure optimal outcomes.
Lyme disease is a multisystem, tick-borne infection caused by spirochetes of the genus Borrelia. It typically begins at the site of a bite from an infected Ixodes tick, followed by local spread in the skin and eventual dissemination through the bloodstream or lymphatic system to multiple organs, including joints, the nervous system, heart, and skin. The disease progresses through three stages: early localized, early disseminated, and late disease. It was first recognized in 1977 after a cluster of arthritis cases in children near Lyme, Connecticut.
Epidemiologically, Lyme disease is the most common tick-borne infection in North America and Europe. The highest incidence occurs in specific endemic regions, particularly along the northeastern United States and parts of the Midwest. Risk is strongly associated with outdoor activities such as hiking, camping, or occupational exposure in wooded or grassy areas where ticks are prevalent. Transmission usually requires the tick to remain attached for more than 36 hours, although many patients do not recall a tick bite. Preventive strategies include wearing protective clothing, using insect repellents such as DEET, and prompt tick removal. In certain high-risk exposures, a single prophylactic dose of doxycycline may be considered.
The causative organism in the United States is Borrelia burgdorferi, while Borrelia afzelii and Borrelia garinii are more common in Europe and Asia. After entering the skin, the organism spreads locally and may later disseminate systemically. The clinical manifestations depend on the stage of the disease and the host immune response.
In early localized disease, the hallmark finding is erythema migrans, an expanding skin lesion that appears days to weeks after the tick bite. It often presents as a red macule or papule that enlarges into a characteristic annular rash with central clearing. This stage may also be accompanied by mild systemic symptoms such as fever, fatigue, and headache.
Early disseminated disease occurs weeks to months later and involves multiple organ systems. Patients may develop multiple secondary skin lesions, migratory musculoskeletal pain, and neurologic manifestations such as meningitis or facial nerve palsy. Cardiac involvement may occur, most commonly presenting as atrioventricular conduction abnormalities. Ocular symptoms and mild hepatitis may also be seen.
Late disease develops months to years after untreated infection and is characterized primarily by chronic arthritis, especially affecting large joints such as the knee. Neurologic complications may include encephalopathy or polyneuropathy. Certain dermatologic manifestations, such as acrodermatitis chronica atrophicans, are more commonly observed in Europe. Some patients may experience persistent symptoms such as fatigue or cognitive difficulties after treatment, a condition referred to as post–Lyme disease syndrome.
Diagnosis is based on clinical findings, history of exposure, and laboratory testing. A two-step serologic approach is recommended, beginning with an enzyme immunoassay or immunofluorescence assay, followed by confirmatory Western blot testing if positive or equivocal. Laboratory testing has limitations, particularly in early disease when antibodies may not yet be detectable. PCR testing may be useful in certain cases, such as analysis of synovial or cerebrospinal fluid.
Treatment depends on the stage and manifestations of the disease. Early disease is typically treated with oral antibiotics such as doxycycline, amoxicillin, or cefuroxime. More severe or disseminated disease, particularly with neurologic or cardiac involvement, may require intravenous therapy with ceftriaxone. The duration of therapy varies from 2 to 4 weeks depending on the clinical scenario. In cases of persistent arthritis or complications, additional supportive or symptomatic treatments may be required.
The prognosis is generally excellent when Lyme disease is recognized and treated early. However, delayed diagnosis may result in chronic complications such as persistent arthritis or neurologic impairment. Careful monitoring and appropriate management of complications are essential to ensure optimal outcomes.
- Published on
Infectious Disease and Microbiology - Lung abscess
A lung abscess is a localized collection of pus within the lung parenchyma, resulting in a cavity formed by necrosis of lung tissue due to microbial infection. It may present as a single large cavity or as multiple smaller abscesses, the latter often referred to as necrotizing pneumonia. Lung abscesses can be classified as primary, occurring in otherwise healthy individuals, or secondary, associated with underlying conditions such as malignancy, bronchiectasis, or immunosuppression. Although more common in the pre-antibiotic era, lung abscesses are now relatively uncommon but remain clinically significant due to potential complications.
The most important risk factor is aspiration of oropharyngeal contents, particularly in individuals with impaired consciousness, dysphagia, or poor dental hygiene. Conditions such as alcoholism, general anesthesia, seizures, and gastroesophageal reflux disease increase the risk of aspiration. Periodontal disease plays a major role by providing a source of anaerobic bacteria. Other risk factors include airway obstruction, immunocompromised states such as HIV or diabetes, and hematogenous spread from infections like right-sided endocarditis.
Pathophysiologically, microorganisms—most commonly anaerobic bacteria—enter the lung through aspiration and proliferate in areas with poor clearance. This leads to tissue necrosis and cavity formation. Less commonly, abscesses arise from septic emboli traveling through the bloodstream. The most frequent causative organisms include anaerobes such as Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species, often in combination with aerobic bacteria. Aerobic pathogens include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with resistant organisms such as MRSA being increasingly recognized.
Clinically, patients typically present with cough producing foul-smelling, purulent sputum, fever, and pleuritic chest pain. In chronic cases, symptoms may persist for weeks and include weight loss, fatigue, night sweats, and malaise. Physical examination may reveal tachycardia, tachypnea, and abnormal lung findings such as crackles, decreased breath sounds, or signs of consolidation. Digital clubbing may develop in longstanding disease.
Diagnosis involves laboratory and imaging studies. Blood tests often show leukocytosis, while sputum cultures may be inconclusive, especially for anaerobic infections. Chest imaging is essential, with radiographs typically showing a cavity with an air–fluid level. CT scanning provides better anatomical detail and helps identify underlying causes such as obstruction or malignancy. Additional procedures such as bronchoscopy or needle aspiration may be required in atypical or nonresponsive cases.
Treatment consists primarily of prolonged antibiotic therapy targeting both anaerobic and aerobic organisms. First-line regimens include clindamycin or beta-lactam/beta-lactamase inhibitor combinations such as ampicillin-sulbactam, followed by oral therapy once clinical improvement occurs. The duration of therapy may extend from several weeks to months, depending on radiologic resolution. Supportive measures such as postural drainage and pulmonary physiotherapy are important adjuncts. In cases unresponsive to medical therapy, percutaneous or surgical drainage may be necessary.
The prognosis is generally good with appropriate treatment, although mortality ranges from 5% to 15%. Poor prognostic factors include large cavity size, delayed diagnosis, underlying comorbidities, and infection with resistant organisms. Complications may include empyema, massive hemoptysis, pneumothorax, and dissemination leading to conditions such as brain abscess. Careful follow-up with serial imaging is required to ensure resolution of the infection.
A lung abscess is a localized collection of pus within the lung parenchyma, resulting in a cavity formed by necrosis of lung tissue due to microbial infection. It may present as a single large cavity or as multiple smaller abscesses, the latter often referred to as necrotizing pneumonia. Lung abscesses can be classified as primary, occurring in otherwise healthy individuals, or secondary, associated with underlying conditions such as malignancy, bronchiectasis, or immunosuppression. Although more common in the pre-antibiotic era, lung abscesses are now relatively uncommon but remain clinically significant due to potential complications.
The most important risk factor is aspiration of oropharyngeal contents, particularly in individuals with impaired consciousness, dysphagia, or poor dental hygiene. Conditions such as alcoholism, general anesthesia, seizures, and gastroesophageal reflux disease increase the risk of aspiration. Periodontal disease plays a major role by providing a source of anaerobic bacteria. Other risk factors include airway obstruction, immunocompromised states such as HIV or diabetes, and hematogenous spread from infections like right-sided endocarditis.
Pathophysiologically, microorganisms—most commonly anaerobic bacteria—enter the lung through aspiration and proliferate in areas with poor clearance. This leads to tissue necrosis and cavity formation. Less commonly, abscesses arise from septic emboli traveling through the bloodstream. The most frequent causative organisms include anaerobes such as Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species, often in combination with aerobic bacteria. Aerobic pathogens include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with resistant organisms such as MRSA being increasingly recognized.
Clinically, patients typically present with cough producing foul-smelling, purulent sputum, fever, and pleuritic chest pain. In chronic cases, symptoms may persist for weeks and include weight loss, fatigue, night sweats, and malaise. Physical examination may reveal tachycardia, tachypnea, and abnormal lung findings such as crackles, decreased breath sounds, or signs of consolidation. Digital clubbing may develop in longstanding disease.
Diagnosis involves laboratory and imaging studies. Blood tests often show leukocytosis, while sputum cultures may be inconclusive, especially for anaerobic infections. Chest imaging is essential, with radiographs typically showing a cavity with an air–fluid level. CT scanning provides better anatomical detail and helps identify underlying causes such as obstruction or malignancy. Additional procedures such as bronchoscopy or needle aspiration may be required in atypical or nonresponsive cases.
Treatment consists primarily of prolonged antibiotic therapy targeting both anaerobic and aerobic organisms. First-line regimens include clindamycin or beta-lactam/beta-lactamase inhibitor combinations such as ampicillin-sulbactam, followed by oral therapy once clinical improvement occurs. The duration of therapy may extend from several weeks to months, depending on radiologic resolution. Supportive measures such as postural drainage and pulmonary physiotherapy are important adjuncts. In cases unresponsive to medical therapy, percutaneous or surgical drainage may be necessary.
The prognosis is generally good with appropriate treatment, although mortality ranges from 5% to 15%. Poor prognostic factors include large cavity size, delayed diagnosis, underlying comorbidities, and infection with resistant organisms. Complications may include empyema, massive hemoptysis, pneumothorax, and dissemination leading to conditions such as brain abscess. Careful follow-up with serial imaging is required to ensure resolution of the infection.
- Published on
Infectious Disease and Microbiology - Listeriosis
Listeriosis is an infection caused by the gram-positive bacterium Listeria monocytogenes, which is commonly transmitted through contaminated food such as unpasteurized dairy products, processed meats, and raw vegetables. Although many individuals may carry the organism asymptomatically in their gastrointestinal tract, it can cause serious invasive disease, particularly in vulnerable populations. The infection may present in several clinical forms, including febrile gastroenteritis, central nervous system involvement, bacteremia, infection during pregnancy, neonatal infection, and focal infections in various organs.
The disease occurs worldwide and may appear as sporadic cases or outbreaks, often linked to food contamination. While listeriosis can affect healthy individuals, those at higher risk include neonates, elderly individuals, pregnant women, and immunocompromised patients. Pregnancy-associated listeriosis is particularly significant, accounting for a substantial proportion of cases and often presenting with mild, flu-like symptoms in the mother but potentially leading to severe fetal complications such as miscarriage, stillbirth, or neonatal infection.
The pathophysiology varies depending on the clinical syndrome. In healthy individuals, ingestion of the organism may lead to a self-limited febrile gastroenteritis. However, in high-risk groups, the bacteria can invade the bloodstream and spread to the central nervous system, causing meningitis or meningoencephalitis. These CNS infections may present subtly, often with mild fever and altered mental status rather than classic meningeal signs. In neonates, infection may present early with sepsis or pneumonia, or later with meningitis, and in severe cases can manifest as granulomatosis infantiseptica, a disseminated and life-threatening condition.
Diagnosis is based on clinical suspicion supported by laboratory findings. Blood cultures and cerebrospinal fluid analysis are key in detecting invasive disease. Imaging, particularly brain MRI, is useful in patients with neurological symptoms. Stool cultures are generally not helpful, and there are no specific clinical signs that definitively establish the diagnosis, making awareness of risk factors and presentations essential.
Treatment depends on the severity and form of the disease. Mild gastroenteritis in immunocompetent individuals may not require antibiotics, whereas invasive disease requires prompt antimicrobial therapy. First-line treatment typically includes ampicillin or penicillin G, often combined with gentamicin in severe cases. Trimethoprim-sulfamethoxazole is an alternative, particularly in patients with allergies. Treatment duration varies from a few days in mild cases to several weeks in CNS or systemic infections. Hospitalization is required for patients with invasive disease.
The prognosis of listeriosis varies widely. While mild forms have an excellent outcome, invasive infections, especially meningitis and endocarditis, are associated with high mortality rates. Complications may include neurological deficits, seizures, and systemic spread of infection. In pregnancy, adverse fetal outcomes are a major concern. Prevention focuses on proper food handling, avoiding high-risk foods such as unpasteurized dairy products, and maintaining good hygiene practices, particularly in high-risk populations.
Listeriosis is an infection caused by the gram-positive bacterium Listeria monocytogenes, which is commonly transmitted through contaminated food such as unpasteurized dairy products, processed meats, and raw vegetables. Although many individuals may carry the organism asymptomatically in their gastrointestinal tract, it can cause serious invasive disease, particularly in vulnerable populations. The infection may present in several clinical forms, including febrile gastroenteritis, central nervous system involvement, bacteremia, infection during pregnancy, neonatal infection, and focal infections in various organs.
The disease occurs worldwide and may appear as sporadic cases or outbreaks, often linked to food contamination. While listeriosis can affect healthy individuals, those at higher risk include neonates, elderly individuals, pregnant women, and immunocompromised patients. Pregnancy-associated listeriosis is particularly significant, accounting for a substantial proportion of cases and often presenting with mild, flu-like symptoms in the mother but potentially leading to severe fetal complications such as miscarriage, stillbirth, or neonatal infection.
The pathophysiology varies depending on the clinical syndrome. In healthy individuals, ingestion of the organism may lead to a self-limited febrile gastroenteritis. However, in high-risk groups, the bacteria can invade the bloodstream and spread to the central nervous system, causing meningitis or meningoencephalitis. These CNS infections may present subtly, often with mild fever and altered mental status rather than classic meningeal signs. In neonates, infection may present early with sepsis or pneumonia, or later with meningitis, and in severe cases can manifest as granulomatosis infantiseptica, a disseminated and life-threatening condition.
Diagnosis is based on clinical suspicion supported by laboratory findings. Blood cultures and cerebrospinal fluid analysis are key in detecting invasive disease. Imaging, particularly brain MRI, is useful in patients with neurological symptoms. Stool cultures are generally not helpful, and there are no specific clinical signs that definitively establish the diagnosis, making awareness of risk factors and presentations essential.
Treatment depends on the severity and form of the disease. Mild gastroenteritis in immunocompetent individuals may not require antibiotics, whereas invasive disease requires prompt antimicrobial therapy. First-line treatment typically includes ampicillin or penicillin G, often combined with gentamicin in severe cases. Trimethoprim-sulfamethoxazole is an alternative, particularly in patients with allergies. Treatment duration varies from a few days in mild cases to several weeks in CNS or systemic infections. Hospitalization is required for patients with invasive disease.
The prognosis of listeriosis varies widely. While mild forms have an excellent outcome, invasive infections, especially meningitis and endocarditis, are associated with high mortality rates. Complications may include neurological deficits, seizures, and systemic spread of infection. In pregnancy, adverse fetal outcomes are a major concern. Prevention focuses on proper food handling, avoiding high-risk foods such as unpasteurized dairy products, and maintaining good hygiene practices, particularly in high-risk populations.
- Published on
Infectious Disease and Microbiology - Lice
Lice infestation, also known as pediculosis, is caused by ectoparasitic insects of the order Phthiraptera that live on human hair and skin. It is not an infection but an infestation, involving three main types depending on location: head lice, body lice, and pubic lice. The causative organisms include Pediculus humanus capitis, Pediculus humanus corporis, and Phthirus pubis. These parasites feed on human blood and complete their life cycle entirely on the host, with eggs (nits) hatching into nymphs that mature into adults within a few weeks.
Head lice infestation is particularly common among school-aged children and spreads mainly through close personal contact. It is not strongly linked to poor hygiene but is associated with crowding and household size. Body lice are more commonly seen in individuals with poor hygiene, especially among homeless populations or in crowded environments such as refugee camps. Pubic lice are typically transmitted through sexual contact and are therefore considered a sexually transmitted condition, often associated with other sexually transmitted infections.
The main symptom of lice infestation is pruritus, which results from a hypersensitivity reaction to lice saliva. The itching varies depending on the site of infestation and may lead to excoriations and secondary bacterial infections. Physical examination is diagnostic, revealing live lice or nits attached to hair shafts or clothing fibers. In head lice, careful combing of wet hair can improve detection. Pubic lice may also affect other coarse hair regions, including eyelashes, and characteristic bluish-gray skin lesions known as maculae ceruleae may appear.
Diagnosis is clinical and does not require laboratory testing. However, in cases of pubic lice, evaluation for coexisting sexually transmitted diseases is recommended. Body lice infestations may be associated with transmission of certain pathogens, including Bartonella quintana and, less commonly, Rickettsia prowazekii, making recognition important in vulnerable populations.
Treatment primarily involves topical insecticides, with permethrin 1% being the first-line therapy for most infestations. Reapplication after 7 to 10 days is often necessary to eradicate newly hatched lice. Alternative treatments include malathion, lindane (with caution due to potential toxicity), and oral ivermectin in selected cases. Proper application technique is essential for treatment success, as resistance or improper use may lead to persistence of infestation.
Supportive measures include washing clothing, bedding, and personal items in hot water, particularly for body lice. For pubic lice affecting the eyelashes, petroleum jelly may be used. Mechanical removal of lice and nits can be helpful but is generally less effective when used alone. The prognosis is excellent with appropriate treatment, although reinfestation can occur if contacts are not treated simultaneously.
Complications are usually mild and include secondary bacterial skin infections due to scratching. In certain cases, particularly with body lice, there is a risk of transmission of systemic infections. Psychological distress, especially among children and caregivers, is also a notable consequence of infestation.
Lice infestation, also known as pediculosis, is caused by ectoparasitic insects of the order Phthiraptera that live on human hair and skin. It is not an infection but an infestation, involving three main types depending on location: head lice, body lice, and pubic lice. The causative organisms include Pediculus humanus capitis, Pediculus humanus corporis, and Phthirus pubis. These parasites feed on human blood and complete their life cycle entirely on the host, with eggs (nits) hatching into nymphs that mature into adults within a few weeks.
Head lice infestation is particularly common among school-aged children and spreads mainly through close personal contact. It is not strongly linked to poor hygiene but is associated with crowding and household size. Body lice are more commonly seen in individuals with poor hygiene, especially among homeless populations or in crowded environments such as refugee camps. Pubic lice are typically transmitted through sexual contact and are therefore considered a sexually transmitted condition, often associated with other sexually transmitted infections.
The main symptom of lice infestation is pruritus, which results from a hypersensitivity reaction to lice saliva. The itching varies depending on the site of infestation and may lead to excoriations and secondary bacterial infections. Physical examination is diagnostic, revealing live lice or nits attached to hair shafts or clothing fibers. In head lice, careful combing of wet hair can improve detection. Pubic lice may also affect other coarse hair regions, including eyelashes, and characteristic bluish-gray skin lesions known as maculae ceruleae may appear.
Diagnosis is clinical and does not require laboratory testing. However, in cases of pubic lice, evaluation for coexisting sexually transmitted diseases is recommended. Body lice infestations may be associated with transmission of certain pathogens, including Bartonella quintana and, less commonly, Rickettsia prowazekii, making recognition important in vulnerable populations.
Treatment primarily involves topical insecticides, with permethrin 1% being the first-line therapy for most infestations. Reapplication after 7 to 10 days is often necessary to eradicate newly hatched lice. Alternative treatments include malathion, lindane (with caution due to potential toxicity), and oral ivermectin in selected cases. Proper application technique is essential for treatment success, as resistance or improper use may lead to persistence of infestation.
Supportive measures include washing clothing, bedding, and personal items in hot water, particularly for body lice. For pubic lice affecting the eyelashes, petroleum jelly may be used. Mechanical removal of lice and nits can be helpful but is generally less effective when used alone. The prognosis is excellent with appropriate treatment, although reinfestation can occur if contacts are not treated simultaneously.
Complications are usually mild and include secondary bacterial skin infections due to scratching. In certain cases, particularly with body lice, there is a risk of transmission of systemic infections. Psychological distress, especially among children and caregivers, is also a notable consequence of infestation.
- Published on
Infectious Disease and Microbiology - Leptospirosis
Leptospirosis is a zoonotic infectious disease caused by the spirochete Leptospira interrogans. It is transmitted primarily through contact with water, soil, or vegetation contaminated with the urine of infected animals, particularly rodents, which serve as the main reservoir. The organism enters the body through abraded skin or mucous membranes and disseminates hematogenously, affecting multiple organs. The disease is globally distributed and often underdiagnosed, with many infections remaining asymptomatic or presenting as nonspecific febrile illness.
Epidemiologically, leptospirosis is more common in tropical and subtropical regions, though it occurs worldwide. It is associated with occupational and recreational exposure, affecting farmers, sewer workers, veterinarians, and individuals exposed to contaminated water such as swimmers or campers. Outbreaks are often linked to flooding and poor sanitation, especially in urban slum settings. The incubation period typically ranges from 1 to 2 weeks but can vary from a few days to several weeks.
Clinically, leptospirosis presents with a wide spectrum of manifestations. The anicteric form is more common and characterized by fever, chills, severe myalgia (especially in the calf muscles), headache, and conjunctival suffusion. The disease may be biphasic, with an initial septicemic phase followed by an immune phase involving meningitis or other organ systems. In severe cases, patients develop icteric leptospirosis, also known as Weil’s syndrome, which is marked by jaundice, renal failure, and hemorrhagic complications. Neurological, respiratory, and gastrointestinal symptoms may also occur, reflecting multisystem involvement.
Diagnosis relies on a combination of clinical suspicion and laboratory testing. Direct visualization of leptospires may be possible using dark-field microscopy in blood, urine, or cerebrospinal fluid early in the disease. Serologic testing, particularly the microscopic agglutination test, is the reference standard, while detection of IgM antibodies and PCR-based methods provide additional diagnostic support. Laboratory abnormalities often include thrombocytopenia, elevated liver enzymes, renal dysfunction, and increased creatine phosphokinase levels. Imaging studies such as chest radiography may be necessary in patients with pulmonary involvement.
Treatment depends on disease severity. Mild cases can be managed with oral antibiotics such as doxycycline or azithromycin, whereas severe disease requires intravenous therapy, most commonly with penicillin G or ceftriaxone for approximately 7 days. Supportive care is crucial, especially in cases complicated by renal failure or respiratory distress, and specialist consultation may be necessary. Early initiation of antibiotics significantly improves outcomes.
The prognosis is generally favorable in mild disease, but severe leptospirosis carries a significant mortality risk, particularly when associated with hepatic and renal failure. Complications include hepatorenal syndrome, acute respiratory distress syndrome, myocarditis, and severe hemorrhage. Preventive measures focus on reducing exposure, including rodent control, use of protective clothing, and in selected high-risk individuals, chemoprophylaxis with doxycycline.
Leptospirosis is a zoonotic infectious disease caused by the spirochete Leptospira interrogans. It is transmitted primarily through contact with water, soil, or vegetation contaminated with the urine of infected animals, particularly rodents, which serve as the main reservoir. The organism enters the body through abraded skin or mucous membranes and disseminates hematogenously, affecting multiple organs. The disease is globally distributed and often underdiagnosed, with many infections remaining asymptomatic or presenting as nonspecific febrile illness.
Epidemiologically, leptospirosis is more common in tropical and subtropical regions, though it occurs worldwide. It is associated with occupational and recreational exposure, affecting farmers, sewer workers, veterinarians, and individuals exposed to contaminated water such as swimmers or campers. Outbreaks are often linked to flooding and poor sanitation, especially in urban slum settings. The incubation period typically ranges from 1 to 2 weeks but can vary from a few days to several weeks.
Clinically, leptospirosis presents with a wide spectrum of manifestations. The anicteric form is more common and characterized by fever, chills, severe myalgia (especially in the calf muscles), headache, and conjunctival suffusion. The disease may be biphasic, with an initial septicemic phase followed by an immune phase involving meningitis or other organ systems. In severe cases, patients develop icteric leptospirosis, also known as Weil’s syndrome, which is marked by jaundice, renal failure, and hemorrhagic complications. Neurological, respiratory, and gastrointestinal symptoms may also occur, reflecting multisystem involvement.
Diagnosis relies on a combination of clinical suspicion and laboratory testing. Direct visualization of leptospires may be possible using dark-field microscopy in blood, urine, or cerebrospinal fluid early in the disease. Serologic testing, particularly the microscopic agglutination test, is the reference standard, while detection of IgM antibodies and PCR-based methods provide additional diagnostic support. Laboratory abnormalities often include thrombocytopenia, elevated liver enzymes, renal dysfunction, and increased creatine phosphokinase levels. Imaging studies such as chest radiography may be necessary in patients with pulmonary involvement.
Treatment depends on disease severity. Mild cases can be managed with oral antibiotics such as doxycycline or azithromycin, whereas severe disease requires intravenous therapy, most commonly with penicillin G or ceftriaxone for approximately 7 days. Supportive care is crucial, especially in cases complicated by renal failure or respiratory distress, and specialist consultation may be necessary. Early initiation of antibiotics significantly improves outcomes.
The prognosis is generally favorable in mild disease, but severe leptospirosis carries a significant mortality risk, particularly when associated with hepatic and renal failure. Complications include hepatorenal syndrome, acute respiratory distress syndrome, myocarditis, and severe hemorrhage. Preventive measures focus on reducing exposure, including rodent control, use of protective clothing, and in selected high-risk individuals, chemoprophylaxis with doxycycline.
- Published on
Infectious Disease and Microbiology - Keratitis
Keratitis refers to inflammation of the cornea that may be caused by infectious or noninfectious processes. Infectious keratitis can result from bacteria, viruses, fungi, or parasites, and bacterial keratitis is often referred to as a corneal ulcer. A major global cause of keratitis-related blindness is trachoma due to Chlamydia trachomatis, which leads to chronic inflammation, eyelid deformities, and corneal scarring.
The condition occurs worldwide, with bacterial keratitis being more common among contact lens users. Risk factors include disruption of the corneal epithelial surface, poor contact lens hygiene, overnight lens use, and ocular trauma. In critically ill patients, factors such as inability to close the eyes, reduced blinking, and dry eye contribute to risk. Fungal keratitis is more common in warm climates and often follows trauma with plant material, while trachoma is associated with poor hygiene and limited access to water.
The pathophysiology involves a break in the corneal epithelium that allows microorganisms to enter and proliferate in the corneal stroma. Some organisms possess adhesins that facilitate attachment to corneal cells. Viral causes such as Herpes simplex virus type 1 can remain latent in the trigeminal ganglion and reactivate, leading to recurrent disease. Similarly, Varicella zoster virus may reactivate later in life, causing herpes zoster ophthalmicus when the trigeminal nerve is involved.
A wide range of organisms can cause keratitis. Bacterial causes include Pseudomonas, Staphylococcus, and Streptococcus species, with Pseudomonas being particularly aggressive in contact lens users. Viral causes include HSV and VZV, with HSV producing characteristic dendritic lesions. Fungal organisms such as Aspergillus and Fusarium cause more indolent infections, while parasites such as Acanthamoeba can produce severe pain and characteristic ring-shaped infiltrates.
Patients typically present with eye pain, redness, foreign body sensation, photophobia, tearing, discharge, and reduced vision. Severe pain that is disproportionate to clinical findings is suggestive of Acanthamoeba infection. Viral keratitis may lead to reduced corneal sensation. Herpes zoster ophthalmicus may be preceded by a flu-like illness and is associated with a dermatomal rash, especially involving the tip of the nose.
On examination, slit-lamp findings include epithelial defects, stromal infiltrates, and anterior chamber inflammation. Fluorescein staining highlights epithelial defects. Severe cases may show hypopyon. Bacterial ulcers may appear as rapidly spreading infiltrates, while fungal keratitis often shows feathery borders and satellite lesions. HSV infection classically produces branching dendritic ulcers, while late Acanthamoeba infection may show a ring infiltrate.
Diagnosis is primarily clinical but supported by laboratory studies. Corneal scrapings are obtained for staining and culture to identify the causative organism. Special stains and media are used depending on suspected pathogens. PCR and viral testing may be used for herpetic infections, while confocal microscopy can help identify Acanthamoeba cysts.
Management depends on the underlying cause but must be initiated promptly. Suspected bacterial keratitis requires immediate empiric broad-spectrum topical antibiotics, often administered hourly. Severe cases may require fortified antibiotic drops. Fungal keratitis is treated with topical antifungals such as natamycin or amphotericin B, often for prolonged periods. Acanthamoeba infections require specific agents such as polyhexamethylene biguanide and are difficult to eradicate. Viral keratitis due to HSV is treated with topical antivirals, while deeper stromal disease may require cautious use of topical steroids along with antiviral coverage. Herpes zoster ophthalmicus is treated with systemic antiviral therapy.
Prognosis depends on the severity, location, and timeliness of treatment. Early treatment generally leads to good outcomes, but delayed therapy can result in significant visual impairment. Complications include corneal scarring, thinning, perforation, and secondary infections such as endophthalmitis. Chronic or recurrent infections, particularly with HSV, may lead to permanent visual loss and require surgical intervention such as corneal transplantation.
